|
US7169777B2
(en)
|
2001-01-23 |
2007-01-30 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
WO2002059117A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
|
|
JP2004532838A
(ja)
|
2001-03-02 |
2004-10-28 |
ブリストル−マイヤーズ スクイブ カンパニー |
メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
|
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7456184B2
(en)
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
US7354923B2
(en)
|
2001-08-10 |
2008-04-08 |
Palatin Technologies, Inc. |
Piperazine melanocortin-specific compounds
|
|
WO2003061660A1
(en)
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
TW200504033A
(en)
*
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
CA2506843A1
(en)
*
|
2002-11-22 |
2004-06-10 |
Novo-Nordisk A/S |
2,5-diketopiperazines for the treatment of obesity
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
PL378754A1
(pl)
|
2003-03-03 |
2006-05-15 |
F.Hoffmann-La Roche Ag |
2,5- i 2,6-Podstawione tetrahydroizochinoliny do stosowania jako modulatory 5-HT6
|
|
WO2004078717A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
EP1468999A1
(en)
*
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
CA2519939A1
(en)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
|
AU2004274309B2
(en)
|
2003-09-22 |
2010-04-08 |
Msd K.K. |
Novel piperidine derivative
|
|
US20050192286A1
(en)
*
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050119252A1
(en)
*
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US7989634B2
(en)
|
2003-11-12 |
2011-08-02 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
US7449481B2
(en)
*
|
2004-04-13 |
2008-11-11 |
Cephalon, Inc. |
Thio-substituted biaryl-methanesulfinyl derivatives
|
|
CA2609388C
(en)
|
2005-05-30 |
2013-08-06 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
EP1921065B1
(en)
|
2005-08-24 |
2010-10-20 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
BRPI0616463A2
(pt)
|
2005-09-29 |
2011-06-21 |
Merck & Co Inc |
composto, composição farmacêutica, e, uso de um composto
|
|
EP1940401B1
(en)
|
2005-10-18 |
2012-07-11 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
WO2007048027A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
US8158791B2
(en)
|
2005-11-10 |
2012-04-17 |
Msd K.K. |
Aza-substituted spiro derivatives
|
|
TWI332501B
(en)
*
|
2006-07-14 |
2010-11-01 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
|
JP5489333B2
(ja)
|
2006-09-22 |
2014-05-14 |
メルク・シャープ・アンド・ドーム・コーポレーション |
脂肪酸合成阻害剤を用いた治療の方法
|
|
AU2007301126A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
CA2682727C
(en)
|
2007-04-02 |
2016-03-22 |
Banyu Pharmaceutical Co., Ltd. |
Indoledione derivative
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
|
EP2272841A1
(en)
|
2008-03-28 |
2011-01-12 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
US8227628B2
(en)
|
2008-07-09 |
2012-07-24 |
Northwestern University |
Method of synthesizing acetonide-protected catechol-containing compounds and intermediates produced therein
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
５員－５員又は５員－６員縮環シクロアルキルアミン誘導体
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
UA99555C2
(en)
|
2008-11-12 |
2012-08-27 |
Элджи Лайф Саенсез Лтд. |
Melanocortin receptor agonists
|
|
JP5514831B2
(ja)
|
2008-11-17 |
2014-06-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病の治療のための置換二環式アミン
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
EP2563764B1
(en)
|
2010-04-26 |
2015-02-25 |
Merck Sharp & Dohme Corp. |
Novel spiropiperidine prolylcarboxypeptidase inhibitors
|
|
US9365539B2
(en)
|
2010-05-11 |
2016-06-14 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
|
US9006268B2
(en)
|
2010-06-11 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
EA030067B1
(ru)
|
2013-07-22 |
2018-06-29 |
Идорсиа Фармасьютиклз Лтд |
Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
AR099789A1
(es)
*
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
KR102431436B1
(ko)
|
2014-08-29 |
2022-08-10 |
테스 파마 에스.알.엘. |
α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
|
JP6337218B2
(ja)
|
2015-01-15 |
2018-06-06 |
イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ |
Ｃｘｃｒ３受容体調節剤としてのヒドロキシアルキル−ピペラジン誘導体
|
|
AR109950A1
(es)
|
2016-10-14 |
2019-02-06 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
MX2020013085A
(es)
*
|
2018-06-05 |
2021-03-02 |
Crinetics Pharmaceuticals Inc |
Antagonistas del receptor de subtipo 2 de melanocortina (mc2r) y usos de los mismos.
|
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
HUE068289T2
(hu)
*
|
2019-08-23 |
2024-12-28 |
Mochida Pharm Co Ltd |
Eljárás heterociklidén-acetamid származékok elõállítására
|
|
CN118812481A
(zh)
*
|
2019-08-23 |
2024-10-22 |
持田制药株式会社 |
杂环亚基乙酰胺衍生物的制造方法
|
|
WO2021039023A1
(ja)
*
|
2019-08-23 |
2021-03-04 |
持田製薬株式会社 |
ヘテロシクリデンアセトアミド誘導体の製造方法
|
|
EP4219473A4
(en)
*
|
2020-10-29 |
2024-03-13 |
Lg Chem, Ltd. |
CRYSTAL TYPE II OF A MALANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR THE PRODUCTION THEREOF
|
|
EP4219474A4
(en)
*
|
2020-10-29 |
2024-03-13 |
Lg Chem, Ltd. |
Crystalline form iii of melanocortin receptor agonist compound and method for preparing same
|
|
CA3195298A1
(en)
*
|
2020-10-29 |
2022-05-05 |
Lg Chem, Ltd. |
Crystalline form i of melanocortin receptor agonist compound and preparation method therefor
|
|
JP2023548162A
(ja)
*
|
2020-10-29 |
2023-11-15 |
エルジー・ケム・リミテッド |
無定形のメラノコルチン－４受容体アゴニスト
|
|
CN116507614A
(zh)
*
|
2020-10-29 |
2023-07-28 |
株式会社Lg化学 |
黑皮质素受体激动剂化合物的晶型iv及其制备方法
|
|
JP2024500966A
(ja)
*
|
2020-12-22 |
2024-01-10 |
エルジー・ケム・リミテッド |
メラノコルチン受容体アゴニスト化合物の結晶形ｉおよびその製造方法
|
|
US20240051919A1
(en)
*
|
2020-12-22 |
2024-02-15 |
Lg Chem, Ltd. |
Crystalline form iii of melanocortin receptor agonist compound and preparation method therefor
|
|
TWI832128B
(zh)
*
|
2020-12-22 |
2024-02-11 |
南韓商Ｌｇ化學股份有限公司 |
使用作為黑皮質素-4受體選擇性促效劑
|
|
CN116648249A
(zh)
*
|
2020-12-22 |
2023-08-25 |
株式会社Lg化学 |
黑皮质素受体激动剂化合物的结晶形式ii及其制备方法
|
|
AU2022209657B2
(en)
*
|
2021-01-21 |
2025-06-05 |
Lg Chem, Ltd. |
Uses of melanocortin-4 receptor agonist
|
|
EP4299572A4
(en)
*
|
2021-02-26 |
2024-07-31 |
Lg Chem, Ltd. |
MELANOCORTIN RECEPTOR 4 AGONIST
|
|
US20240239783A1
(en)
*
|
2021-05-06 |
2024-07-18 |
Lg Chem, Ltd. |
Crystal form vii of melanocortin receptor agonist compound and method for preparing same
|
|
US20240228473A1
(en)
*
|
2021-05-06 |
2024-07-11 |
Lg Chem, Ltd. |
Crystalline form v of melanocortin receptor agonist compound, and method for preparing same
|
|
CN117242063A
(zh)
*
|
2021-05-07 |
2023-12-15 |
株式会社Lg化学 |
黑皮质素受体激动剂化合物与香兰素的共晶及其制备方法
|
|
AU2022271120A1
(en)
*
|
2021-05-07 |
2023-11-09 |
Lg Chem, Ltd. |
Crystal form iv of organic acid salts of melanocortin receptor agonist compound, and preparation method thereof
|
|
BR112023022334A2
(pt)
*
|
2021-05-07 |
2023-12-26 |
Lg Chemical Ltd |
Formas cristalinas de sulfato do composto agonista do receptor de melanocortina, seus métodos de preparação, seus usos, e composições farmacêuticas compreendendo as mesmas
|